Team:NJU China/Parts
From 2013.igem.org
(Difference between revisions)
(One intermediate revision not shown) | |||
Line 401: | Line 401: | ||
</head> | </head> | ||
<body> | <body> | ||
- | <div style="float:left; position:static; margin-top: | + | <div style="float:left; position:static; margin-top:-15px;margin-left:-60px; z-index:1; display:block; "> |
</br></br> | </br></br> | ||
<a href="https://2013.igem.org"><img src="https://static.igem.org/mediawiki/2013/8/80/NJU-Miniminiminilogocolored.png" ></a> | <a href="https://2013.igem.org"><img src="https://static.igem.org/mediawiki/2013/8/80/NJU-Miniminiminilogocolored.png" ></a> | ||
Line 407: | Line 407: | ||
<div class="container"> | <div class="container"> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<!--Start NavBar--> | <!--Start NavBar--> | ||
<ul id="nav"> | <ul id="nav"> | ||
Line 420: | Line 413: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Project">Project</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Project</a> | ||
<ul> | <ul> | ||
- | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Overview</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Chassis</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Targeting Module</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Killing Module</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/Project | + | <li><a href="https://2013.igem.org/Team:NJU_China/Project">Achievement</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 432: | Line 425: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Human Practice</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Human Practice</a> | ||
<ul> | <ul> | ||
- | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Free debate</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Reach the unreached</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Workshop</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Human Practice">Collaboration</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 441: | Line 434: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Wet lab">Wet lab</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Wet lab">Wet lab</a> | ||
<ul> | <ul> | ||
- | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Protocol">Protocol</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Notebook">Lab notes</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Data Page">Data Page</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Parts">Parts</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 450: | Line 443: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety</a> | ||
<ul> | <ul> | ||
- | <li><a href=" | + | <li><a href="https://2013.igem.org/Team:NJU_China/Safety">Safety form</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Virus-related_safety">Virus-related safety</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 459: | Line 452: | ||
<li><a href="https://2013.igem.org/Team:NJU_China/Extras">Extras</a> | <li><a href="https://2013.igem.org/Team:NJU_China/Extras">Extras</a> | ||
<ul> | <ul> | ||
- | <li><a href=" | + | <li><a href="https://igem.org/2013_Judging_Form?id=1180">Judging criteria</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Attributions">Attribution</a></li> |
- | <li><a href="https://2013.igem.org/Team:NJU_China/ | + | <li><a href="https://2013.igem.org/Team:NJU_China/Acknowledgement">Acknowledgement</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
+ | |||
</br> <li><a href="https://2013.igem.org/Team:NJU_China/Notebook">Notebook</a> | </br> <li><a href="https://2013.igem.org/Team:NJU_China/Notebook">Notebook</a> | ||
Line 472: | Line 466: | ||
<!--End NavBar--> | <!--End NavBar--> | ||
</br></br></br> | </br></br></br> | ||
+ | |||
+ | <header> | ||
+ | <h1>parts</h1> | ||
+ | </header> | ||
+ | |||
+ | |||
<section> | <section> | ||
<p> | <p> |
Latest revision as of 09:11, 28 October 2013
<!DOCTYPE html>
parts
This year our team iGEM-China constructed altogether 3 parts.
For the killing module, we constructed plasmid encoding anti-HBV siRNA 467(BBa_K1180000) and cloned this into standardized backbone pSB1C3. The function of this part was extensively validated by us and it worked as we expected. The expression level of this plasmid in the chassis HEK 293T cells is high and it can silence the viral gene HBsAG significantly.
For the targeting module, we constructed BBa_K1180002 (brain targeting) and BBa_K1180003 (liver targeting). The function of was extensively confirmed by both in vitro and in vivo test. After its expression, the RVG peptide can lead the exosome to the brain.